
Evidence-Based Medicine, Doripenem, Cilastatin, Imipenem Drug Combination, Pneumonia, Ventilator-Associated, Risk Assessment, Anti-Bacterial Agents, Drug Combinations, Imipenem, Treatment Outcome, Carbapenems, Cilastatin, Risk Factors, Early Termination of Clinical Trials, Humans, Randomized Controlled Trials as Topic
Evidence-Based Medicine, Doripenem, Cilastatin, Imipenem Drug Combination, Pneumonia, Ventilator-Associated, Risk Assessment, Anti-Bacterial Agents, Drug Combinations, Imipenem, Treatment Outcome, Carbapenems, Cilastatin, Risk Factors, Early Termination of Clinical Trials, Humans, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
